Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by The Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to prevention options
ReiThera Srl, the Ragon Institute of Mass General, MIT, and Harvard, and IAVI are pleased to announce a collaboration to develop a novel HIV vaccine candidate that will be composed of ReiThera’s GRAd vector and HIV T cell epitopes identified by the Ragon Institute, funded by the Bill & Melinda Gates Foundation.
